Interaction of Cryptosporidium parvum with mouse dendritic cells leads to their activation and parasite transportation to mesenteric lymph nodes

Pathogens and Disease

Volumn 70, Issue 1, 2014, Pages 17-27

  Perez Cordon, Gregorio ^a   Yang, Guilin ^b   Zhou, Boping ^b   Nie, Weijia ^a   Li, Shan ^c   Shi, Lianfa ^c   Tzipori, Saul ^a   Feng, Hanping ^c  

^a TUFTS UNIVERSITY   (United States)

^b Shenzhen East Lake Hospital   (China)

^c UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

Author keywords

Cryptosporidium parvum; Dendritic cell; Mesenteric lymph node

Indexed keywords

ACTIN; B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; PARASITE ANTIGEN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CRYPTOSPORIDIUM PARVUM; CYTOKINE PRODUCTION; DENDRITIC CELL; HOST CELL; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PARASITE; PRIORITY JOURNAL; UPREGULATION;

CRYPTOSPORIDIUM PARVUM; DENDRITIC CELL; MESENTERIC LYMPH NODE;

ANIMALS; BONE MARROW CELLS; CELL LINE; CELL MEMBRANE; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DENDRITIC CELLS; INTERLEUKIN-12; INTERLEUKIN-6; LYMPH NODES; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84902268706     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1111/2049-632X.12078     Document Type: Article

References (47)

1. Abreu MT, Fukata M & Arditi M (2005) TLR signaling in the gut in health and disease. J Immunol 174: 4453-4460.
2. Banchereau J & Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392: 245-252.
3. Bedi B & Mead JR (2012) Cryptosporidium parvum antigens induce mouse and human dendritic cells to generate Th-1 enhancing cytokines. Parasite Immunol 34: 473-485.
4. Bierly AL, Shufesky WJ, Sukhumavasi W, Morelli AE & Denkers EY (2008) Dendritic cells expressing plasmacytoid marker PDCA-1 are trojan horses during Toxoplasma gondii Infection. J Immunol 181: 8485-8491.
5. Castellaneta A, Abe M, Morelli AE & Thomson AW (2004) Identification and characterization of intestinal Peyer's patch interferon-alpha producing (Plasmacytoid) dendritic cells. Hum Immunol 65: 104-113.
6. Chen WX, Harp JA & Harmsen AG (1993) Requirements for CD4+ cells and gamma-interferon in resolution of established Cryptosporidium parvum infection in mice. Infect Immun 61: 3928-3932.
7. Chen XM, O'Hara SP, Nelson JB, Splinter PL, Small AJ, Tietz PS, Limper AH & LaRusso NF (2005) Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-kappaB. J Immunol 175: 7447-7456.
8. Courret N, Darche S, Sonigo P, Milon G, Buzoni-Gatel D, Tardieux I (2006) CD11c- and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood 107: 309-316.
9. Dupont C, Bougnoux ME, Turner L, Rouveix E & Dorra M (1996) Microbiological findings about pulmonary cryptosporidiosis in two AIDS patients. J Clin Microbiol 34: 227-229.
10. Ehigiator HN, McNair N & Mead JR (2003) IL-12 knockout C57BL/6 mice are protected from re-infection with Cryptosporidium parvum after challenge. J Eukaryot Microbiol 50: 539-541.
11. Elliott DA & Clark DP (2000) Cryptosporidium parvum induces host cell actin accumulation at the host-parasite interface. Infect Immun 68: 2315-2322.
12. Feng HP, Zhang D, Palliser D, Zhu PC, Cai SH, Schlesinger A, Maliszewski L & Lieberman J (2005) Listeria-infected myeloid dendritic cells produce IFN-beta priming T cell activation. J Immunol 175: 421-432.
13. Feng H, Nie W, Bonilla R, Widmer G, Sheoran A & Tzipori S (2006) Quantitative tracking of Cryptosporidium infection in cell culture with CFSE. J Parasitol 92: 1350-1354.
14. Gentile G, Baldassarri L, Caprioli A, Donelli G, Venditti M, Avvisati G & Martino P (1987) Colonic vascular invasion as a possible route of extraintestinal cryptosporidiosis. Am J Med 82: 574-575.
15. Guermonprez P, Valladeau J, Zitvogel L, Thery C & Amigorena S (2002) Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 20: 621-667.
16. Heiges M, Wang H, Robinson E et al. (2006) CryptoDB: a Cryptosporidium bioinformatics resource update. Nucleic Acids Res 34: D419-D422.
17. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, Ogarra A & Murphy KM (1993) Development of Th1 CD4+ T-cells through IL-12 produced by Listeria-induced macrophages. Science 260: 547-549.
18. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S & Steinman RM (1992) Generation of large numbers of dendritic cells from mouse bone-marrow cultures supplemented with granulocyte macrophage colony-stimulating factor. J Exp Med 176: 1693-1702.
19. Kaech SM & Ahmed R (2001) Memory CD8(+) T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat Immunol 2: 415-422.
20. Kamau SW, Hurtado M, Muller-Doblies UU, Grimm F & Nunez R (2000) Flow cytometric assessment of allopurinol susceptibility in Leishmania infantum promastigote. Cytometry 40: 353-360.
21. Lacroix S, Mancassola R, Naciri M & Laurent F (2001) Cryptosporidium parvum-specific mucosal immune response in C57BL/6 neonatal and gamma interferon-deficient mice: role of tumor necrosis factor alpha in protection. Infect Immun 69: 1635-1642.
22. Lean IS, Lacroix-Lamande S, Laurent F & McDonald V (2006) Role of tumor necrosis factor alpha in development of immunity against Cryptosporidium parvum infection. Infect Immun 74: 4379-4382.
23. Lopez-velez R, Tarazona R, Camacho AG, Gomez-Mampaso EG, Guerrero A, Moreira V & Villanueva R (1995) Intestinal and extraintestinal cryptosporidiosis in AIDS patients. Eur J Clin Microbiol Infect Dis 14: 677-681.
24. Lyons AB (2000) Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J Immunol Methods 243: 147-154.
25. McDonald V (2000) Host cell-mediated responses to infection with Cryptosporidium. Parasite Immunol 22: 597-604.
26. Mowat AM (2003) Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 3: 331-341.
27. Niess JH, Brand S, Gu XB, Landsman L, Jung S et al. (2005) CX(3)CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307: 254-258.
28. Okhuysen PC, Rich SM, Chappell CL, Grimes KA, Widmer G, Feng X & Tzipori S (2002) Infectivity of a Cryptosporidium parvum isolate of cervine origin for healthy adults and interferon-gamma knockout mice. J Infect Dis 185: 1320-1325.
29. Perez-Cordon G, Nie W, Schmidt D, Tzipori S & Feng H (2011) Involvement of host calpain in the invasion of Cryptosporidium parvum. Microbes Infect 13: 103-107.
30. Persson CM, Lambert H, Vutova PP, Dellacasa-Lindberg I, Nederby J, Yagita H, Ljunggren HG, Grandien A, Barragan A & Chambers BJ (2009) Transmission of Toxoplasma gondii from infected dendritic cells to natural killer cells. Infect Immun 77: 970-976.
31. Pollok RCG, Farthing MJG, Bajaj-Elliott M, Sanderson IR & McDonald V (2001) Interferon gamma induces enterocyte resistance against infection by the intracellular pathogen Cryptosporidium parvum. Gastroenterology 120: 99-107.
32. Ponnuraj EM & Hayward AR (2001) Intact intestinal mRNAs and intestinal epithelial cell esterase, but not Cryptosporidium parvum, reach mesenteric lymph nodes of infected mice. J Immunol 167: 5321-5328.
33. Prina E, Abdi SZ, Lebastard M, Perret E, Winter N & Antoine JC (2004) Dendritic Cells as host cells for the promastigote and amastigote stages of Leishmania amazonensis: the role of opsonins in parasite uptake and dendritic cell maturation. J Cell Sci 117: 315-325.
34. Re F & Strominger JL (2004) Heterogeneity of TLR-induced responses in dendritic cells: from innate to adaptive immunity. Immunobioly 204: 191-198.
35. Reis e Sousa C (2001) Dendritic cells as sensors of infection. Immunity 14: 495-498.
36. Rogers KA, Rogers AB, Leav BA, Sanchez A, Vannier E, Uematsu S, Akira S, Golenbock D & Ward HD (2006) MyD88-dependent pathways mediate resistance to Cryptosporidium parvum infection in mice. Infect Immun 74: 549-556.
37. Rybicka JM, Balce DR, Chaudhuri S, Allan ERO & Yates RM (2012) Phagosomal proteolysis in dendritic cells is modulated by NADPH oxidase in a pH-independent manner. EMBO J 31: 932-944.
38. Shen ZH, Reznikoff G, Dranoff G & Rock KL (1997) Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 158: 2723-2730.
39. Sheoran AS, Feng XC, Kitaka S, Green L, Pearson C, Didier ES, Chapman S, Tumwine JK & Tzipori S (2005) Purification of Enterocytozoon bieneusi from stools and production of specific antibodies. J Clin Microbiol 43: 387-392.
40. Smith HV, Nichols RAB & Grimason AM (2005) Cryptosporidium excystation and invasion: getting to the guts of the matter. Trends Parasitol 21: 133-142.
41. Steinman RM & Cohn ZA (1973) Identification of a novel cell type in peripheral lymphoid organs of mice. J Exp Med 137: 1142-1162.
42. Stinear T, Matusan A, Hines K & Sandery M (1996) Detection of a single viable Cryptosporidium parvum oocyst in environmental water concentrates by reverse transcription-PCR. Appl Environ Microbiol 62: 3385-3390.
43. Stoll S, Delon J, Brotz TM & Germain RN (2002) Dynamic imaging of T cell-dendritic cell interactions in lymph nodes. Science 296: 1873-1876.
44. Tzipori S (1998) Cryptosporidiosis: laboratory investigations and chemotherapy. Adv Parasitol 40: 187-221.
45. Tzipori S & Ward H (2002) Cryptosporidiosis: biology, pathogenesis and disease. Microbes Infect 4: 1047-1058.
46. Urban JF, Fayer R, Chen SJ, Gause WC, Gately MK et al. (1996) IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum. J Immunol 156: 263-268.
47. Widmer G, Orbacz EA & Tzipori S (1999) beta-tubulin mRNA as a marker of Cryptosporidium parvum oocyst viability. Appl Environ Microbiol 65: 1584-1588.